Tourmaline Bio Inc (TRML)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TRML | SVRA | XERS | ||
| Company | Tourmaline Bio Inc | Savara Inc | Xeris Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 47.98 | 6.47 | 7.22 | ||
| High | 48.00 | 6.61 | 7.32 | ||
| Low | 47.98 | 6.33 | 7.17 | ||
| Latest | 47.98 | 6.40 | 7.21 | ||
| Change | unch | -0.04 | -0.07 | ||
| % Change | unch | -0.62% | -0.96% | ||
| Volume | 783,700 | 662,700 | 781,000 | ||
| 20-Day Average Volume | 653,225 | 4,304,465 | 2,085,305 | ||
| Previous Close | 47.98 | 6.44 | 7.28 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 47.90 | 6.33 | 7.00 | ||
| 20-Day Raw Stochastic | 92.00% | 68.41% | 75.90% | ||
| 20-Day Relative Strength | 88.61 | 63.32 | 47.57 | ||
| Weighted Alpha | +50.87 | +133.30 | +93.61 | ||
| Today's Opinion | 100% Buy | 100% Buy | 24% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 24% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.10% since 10/20/25 | +4.75% since 12/17/25 | +3.15% since 12/17/25 | ||
| Low | 47.90 on 10/21/25 | 5.86 on 12/22/25 | 6.97 on 12/19/25 | ||
| High | 48.00 on 10/27/25 | 6.64 on 12/23/25 | 7.45 on 12/19/25 | ||
| 1-Month | |||||
| %Chg | +0.50% since 09/26/25 | +22.84% since 11/24/25 | +2.41% since 11/24/25 | ||
| Low | 47.75 on 09/30/25 | 5.09 on 11/26/25 | 6.47 on 12/05/25 | ||
| High | 48.27 on 09/29/25 | 7.01 on 12/12/25 | 7.45 on 12/19/25 | ||
| 3-Month | |||||
| %Chg | +142.69% since 07/25/25 | +82.34% since 09/24/25 | -9.88% since 09/24/25 | ||
| Low | 19.75 on 08/08/25 | 3.34 on 10/08/25 | 6.47 on 12/05/25 | ||
| High | 48.27 on 09/29/25 | 7.01 on 12/12/25 | 10.08 on 11/05/25 | ||
| 6-Month | |||||
| %Chg | +184.07% since 04/25/25 | +180.70% since 06/24/25 | +54.72% since 06/24/25 | ||
| Low | 13.27 on 05/20/25 | 1.98 on 07/01/25 | 4.52 on 07/02/25 | ||
| High | 48.27 on 09/29/25 | 7.01 on 12/12/25 | 10.08 on 11/05/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,232,702 | 1,302,195 | 1,196,312 | ||
| Shares Outstanding, K | 25,692 | 203,468 | 165,924 | ||
| Annual Sales | 0 | 0 | 203,070,000 | ||
| Annual Net Income | -73,210,000 | -95,880,000 | -54,840,000 | ||
| Last Quarter Sales | 0 | 0 | 74,380,000 | ||
| Last Quarter Net Income | -23,090,000 | -29,560,000 | 620,000 | ||
| 60-Month Beta | 2.27 | 0.23 | 0.57 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.90 on 08/13/25 | -0.14 on 11/12/25 | 0.00 on 11/06/25 | ||
| Latest Earnings Date | 11/06/25 | 03/26/26 | 03/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||